Pregunta 1
Pregunta 2
Respuesta
-
increases drugs metabolism
-
decreases drug metabolism
-
decreases plasma concentrations of methylxanthines
-
doesn’ t change drugs metabolism
Pregunta 3
Pregunta
Nocebo effect is
Pregunta 4
Pregunta
When patient and doctor are aware of the contents of the formulation, the trial is defined as
Respuesta
-
open trial
-
blind trial
-
placebo trial
-
double-blind trial
Pregunta 5
Pregunta
Surrogates in rational pharmacotherapy are
Pregunta 6
Pregunta
Pharmacodynamic changes in elderly are
Respuesta
-
increased sensitivity to drugs suppressing central nervous system
-
decreased sensitivity to drugs suppressing central nervous system
-
paradoxal reactions are observed
-
adverse drug reactions are more frequent
Pregunta 7
Pregunta
Steady-state plasma concentration is
Respuesta
-
blood concentration of the drug 2 hours after administration
-
blood concentration of the drug after repeated administration when there is a balance between absorption and excretion
-
blood concentration of the drug after it has been ceased
-
blood concentration of the drug during its absorption
Pregunta 8
Pregunta
Drugs half-life is an index for
Respuesta
-
the route of administration of the drug
-
the duration of the drug effect when there is a relationship between it and plasma concentrations
-
time to reach steady-state plasma concentration after repeated administration
-
determination of dose interval
Pregunta 9
Pregunta
Drugs contraindicated in the first half of pregnancy are
Respuesta
-
Erythromycin
-
Sex steroids
-
Penicillins
-
Oral anticoagulants
Pregunta 10
Pregunta
For pharmacokinetics in elderly is true
Pregunta 11
Pregunta
Reasons for inadequate pharmaceutical availability are
Respuesta
-
chronic renal failure
-
improper use of the drug formulation
-
bad quality of the drug substance
-
participating in treatment
Pregunta 12
Pregunta
Categories of ADRs are
Respuesta
-
certain
-
probable
-
possible
-
unlikely
Pregunta 13
Pregunta
Therapeutic drug monitoring is
Respuesta
-
method for neuroleptanalgesy
-
used when there is relationship between plasma concentrations and drug effect
-
used for drugs with narrow therapeutic window
-
used for drugs with long half- live
Pregunta 14
Pregunta
Irrational ready-made drug formulations contain
Respuesta
-
drugs with different half-life
-
drugs for ethiotropic and symptomatic treatment
-
drugs with narrow therapeutic window
-
drugs affecting different pathogenic mechanisms
Pregunta 15
Pregunta
First phase of clinical trial can be determinated as
Respuesta
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Pregunta 16
Pregunta
Binding of drugs with plasma proteins is important for
Pregunta 17
Pregunta
Adverse drug reactions lead to
Respuesta
-
increased pharmacological effect
-
decreased risk of toxicity
-
decreased efficacy of the treatment
-
developement of unpredictable drug effects
Pregunta 18
Pregunta
Bad compliance of the patient may be due to
Respuesta
-
dose regimen with many drugs with frequent administration
-
a large number of drugs
-
lack of information for the treatment
-
the drug must be taken once daily
Pregunta 19
Pregunta
Fourth phase of clinical trial can be determinated as
Respuesta
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Pregunta 20
Pregunta
Drugs clearance is
Respuesta
-
Amount of drug, that reaches systemic circulation
-
Blood plasma volume from which the drug is eliminated for defined period of time
-
Steady- state plasma concentration
-
Withdrawal syndrome
Pregunta 21
Pregunta
Monitoring of therapeutic plasma concentrations is necessary for
Respuesta
-
theophyllin
-
phenobarbital
-
carbamazepin
-
amoxicillin
Pregunta 22
Pregunta
Third phase of clinical trial can be determinated as
Respuesta
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Pregunta 23
Pregunta
Clearance is an index for
Pregunta 24
Pregunta
Pharmacogenetic differences lead to
Pregunta 25
Pregunta
Drug surveillance is done by
Respuesta
-
spontaneous reporting
-
observation studies
-
family doctors
-
population statistics
Pregunta 26
Pregunta
Adverse drug reactions are the following types
Respuesta
-
augmented
-
bizarre
-
chronic
-
delayed
Pregunta 27
Pregunta
Mechanisms of drug interactions are
Respuesta
-
unpredictable
-
pharmacokinetic
-
pharmacodynamic
-
pharmaceutical
Pregunta 28
Pregunta
The quality of therapeutic decision (outcomes) can be measured by
Respuesta
-
clinical outcomes
-
costs — direct and indirect
-
functional status pf patient
-
overall patient satisfaction
Pregunta 29
Pregunta
Method of evaluation of cost/benefits ration are
Respuesta
-
cost minimization analysis
-
cost effectiveness analysis
-
cost utility analysis
-
cost consequence analysis
Pregunta 30
Pregunta
Drug metabolism involving some enzyme defects includes the following reactions
Respuesta
-
acetylation
-
oxidation
-
hydrolysis
-
red cells enzyme defects
Pregunta 31
Pregunta
The reasons for drug abuse are
Respuesta
-
relief of anxiety, tension and depression
-
entertainment, fun
-
improvement of performance in competitive sports
-
conformity with own social subgroup
Pregunta 32
Pregunta
How many types of dependence do you know?
Respuesta
-
psychological
-
physical (physiological)
-
acute
-
chronic
Pregunta 33
Pregunta
Which pharmacological drug groups cause drug dependence and tolerance?
Respuesta
-
Opioid analgesics
-
Antidepressants
-
CNS stimulants
-
Benzodiazepines
Pregunta 34
Pregunta
The neuropharmacological mechanisms of drug addiction are
Respuesta
-
activation of endogenous opiate encephalin receptors
-
activation of μ-opioid receptors in the brain
-
activation of cannabinoid receptors (CB1) in the hypothalamus
-
increase of glutamate release in the brain cortex
Pregunta 35
Pregunta
Benzodiazepine withdrawal syndrome is characterized by
Respuesta
-
it develops after 6-weeks of treatment
-
it develops after 2 weeks of treatment
-
psychological symptoms — anxiety, agitation, insomnia, seizures
-
physical symptoms — nausea, vomiting, muscle pain, ataxia
Pregunta 36
Pregunta
Opioid (heroin, morphine) withdrawal syndrome is characterized by
Respuesta
-
begins 8 hours after last dose
-
the peak is between 36-72 h
-
first physical symptoms are lacrimation, rhinorrhea and sweating
-
abdominal cramps, diarrhoea, bone and muscle pain, weakness and chills
Pregunta 37
Pregunta
Why is methadone used for treatment of opioid-dependence?